EFFECT OF QURS-E- ASBI IN THE MANAGEMENT OF DIABETIC PERIPHERAL NEUROPATHY- A CASE SERIES

Sadaf*, Md. Rizwanullah, Prof. Tabassum Latafat

ABSTRACT

Background: Diabetic Peripheral Neuropathy (DPN) is one of the most significant microvascular and troublesome complications of Diabetes Mellitus, leading to great morbidity and mortality. It imposes a considerable burden on patients' quality of life and the healthcare system. Unfortunately, current therapies that reduce symptoms of Diabetic Peripheral Neuropathy do not prevent the progression of the disease. Therefore, the search for safe and effective drugs for its management is quite necessary. Unani Medicine is the thrusting area of research to control or reduce the complications of Diabetes. Methodology: In the present study, 10 patients of Diabetes Mellitus Type 2 with Diabetic Peripheral Neuropathy (DPN) were enrolled based on clinical symptoms and confirmed by VPT, done with the help of Diabetic Risk Profiler. Patients were given Qurs-e-Asbi in the dose of 500mg twice a day for 45 days and were followed fortnightly for assessing improvement in VPT and clinical symptoms. Results: Qurs-e-Asbi is found to be significantly effective in reducing both subjective (pain, numbness, weakness, tingling) and objective (VPT) parameters, with a p-value < 0.01. Conclusions: Qurs-e-Asbi can be effectively used in managing Diabetic Peripheral Neuropathy.

Keywords: Qurs-e- Asbi, Diabetic Peripheral Neuropathy, Diabetic Risk Profiler.